Trade PSNL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Personalis, Inc. (PSNL) is trading at US$16.04, up 0.88% today as of Oct 15, 10:15 EDT. The company has a market capitalisation of US$1.96B. Over the past 52 weeks, PSNL has traded between US$4.96 and US$18.89. On Syfe you can trade PSNL with $0 commission and add it to your watchlist.
| Previous close | US$15.90 |
|---|---|
| Market cap | US$1.96B |
| 52-week range | US$4.96 – US$18.89 |
| Volume | 3.26M |
| Exchange | US |
Personalis, Inc.
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
Year: 2019
Sector Update: Healthcare Stocks Softer Late Afternoon
Aug 24, 7:47 PM · MT Newswires
Sector Update: Healthcare
Aug 24, 7:26 PM · MT Newswires
Personalis Shares Fall After Craig-Hallum Downgrade
Aug 24, 6:17 PM · MT Newswires
Craig-Hallum Downgrades Personalis to Hold From Buy, Price Target is $16.25
Aug 24, 1:07 PM · MT Newswires
Personalis, Inc. (PSNL) stock is trading at US$16.04, +0.88% from the previous close of US$15.90.
The market cap for Personalis, Inc. (PSNL) stock is approximately US$1.96B.
The 52-week high for Personalis, Inc. (PSNL) stock is US$18.89.
The 52-week low for Personalis, Inc. (PSNL) stock is US$4.96.
Personalis, Inc. (PSNL) does not currently pay a dividend.
Stay on top of PSNL
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
